- Report
- January 2025
- 175 Pages
Global
From €3977EUR$4,490USD£3,446GBP
- Report
- August 2023
- 1500 Pages
Global
From €7751EUR$8,750USD£6,716GBP
- Report
- April 2024
- 318 Pages
Global
From €4385EUR$4,950USD£3,799GBP
- Report
- May 2024
- 318 Pages
Global
From €3720EUR$4,200USD£3,224GBP
- Report
- October 2023
- 207 Pages
India
From €1749EUR$1,975USD£1,516GBP
€3499EUR$3,950USD£3,032GBP
- Report
- July 2023
- 284 Pages
Global
From €2436EUR$2,750USD£2,111GBP
€4872EUR$5,500USD£4,221GBP
- Report
- August 2021
- 104 Pages
Global
From €3787EUR$4,275USD£3,281GBP
- Report
- April 2023
- 160 Pages
Global
From €5271EUR$5,950USD£4,567GBP
- Report
- May 2024
- 181 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Report
- March 2025
- 85 Pages
Saudi Arabia
From €2635EUR$2,975USD£2,283GBP
€3100EUR$3,500USD£2,686GBP
From €2635EUR$2,975USD£2,283GBP
€3100EUR$3,500USD£2,686GBP
- Report
- October 2023
- 182 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Report
- February 2024
- 112 Pages
Global
From €4208EUR$4,750USD£3,646GBP
- Report
- April 2023
- 114 Pages
Global
From €4208EUR$4,750USD£3,646GBP
- Report
- May 2024
- 182 Pages
Global
From €3388EUR$3,825USD£2,936GBP
€3986EUR$4,500USD£3,454GBP
- Report
- August 2022
- 115 Pages
Global
From €3986EUR$4,500USD£3,454GBP
- Report
- March 2023
- 210 Pages
Global
From €3188EUR$3,599USD£2,762GBP
- Report
- May 2023
- 80 Pages
United States
From €1329EUR$1,500USD£1,151GBP
- Report
- May 2023
- 80 Pages
United Kingdom
From €1329EUR$1,500USD£1,151GBP
From €1329EUR$1,500USD£1,151GBP

The Antimicrobial Susceptibility Testing (AST) market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. AST is used to determine the effectiveness of antibiotics against a particular strain of bacteria, and is used to guide clinical decisions in the treatment of infectious diseases. AST tests are used to identify the most effective antibiotic for a particular infection, and to detect the emergence of antibiotic resistance. AST tests are used in both clinical and research settings, and are becoming increasingly important as antibiotic resistance continues to rise.
The AST market is driven by the increasing prevalence of infectious diseases, the growing demand for rapid and accurate diagnosis, and the need for personalized medicine. The market is further supported by the increasing adoption of automated systems, which reduce the time and cost associated with manual testing.
Notable companies in the AST market include bioMérieux, Becton Dickinson, Thermo Fisher Scientific, Bruker, and Hologic. Show Less Read more